Vanda Pharmaceuticals | VNDA - Ebit





Ebit Veränderung Datum
Acadia Pharmaceuticals USD 71.72M 33.88M 2026-09
Agios Pharmaceuticals USD -110.55M 527K 2026-06
Akebia Therapeutics USD -5.45M 9.4M 2025-12
Alnylam Pharmaceuticals USD 179.66M 67.06M 2026-09
Anika Therapeutics USD 646K 3.88M 2025-12
Arrowhead Research USD -154.34M 13.08M 2026-06
AstraZeneca USD 4.66B 1.5B 2026-09
Bristol-Myers Squibb USD 255M 44M 2026-09
Eli Lilly USD 13.09B 635M 2026-09
Enanta Pharmaceuticals USD -23.54M 6.31M 2024-12
Halozyme Therapeutics USD -60.68M 3.04M 2026-09
Heron Therapeutics USD 38K 3.83M 2025-12
Insmed USD -81.83M 19.48M 2026-09
J&J USD 6.47B 1B 2026-09
Lexicon Pharmaceuticals USD -14.78M 2.59M 2025-12
Ligand Pharmaceuticals USD 54.53M 2.1M 2026-09
Merck USD 7.33B 6.49B 2026-09
Minerva Neurosciences USD -4.37M 1.71M 2024-09
Moderna USD 130M 945M 2026-09
Novartis USD 1.78B 2.4B 2026-09
Pfizer USD 4.85B 5.03B 2026-09
PTC Therapeutics USD 146.03M 100.14M 2026-06
Puma Biotechnology USD -2.2M 11.41M 2024-06
Sanofi EUR 4.72B 3.6B 2026-09
Takeda JPY 205.32B 3.9B 2026-09
Teva Pharmaceutical Industries USD 1.19B 954M 2026-09
Ultragenyx Pharmaceutical USD -110M 35M 2026-09
Vanda Pharmaceuticals USD -10.28M 721K 2024-12
Veracyte USD 18.02M 5.94M 2026-09